TY - JOUR T1 - Prevalence of anaemia in COPD: Less than what has been published before JF - European Respiratory Journal JO - Eur Respir J VL - 38 IS - Suppl 55 SP - 2935 AU - Lorena Comeche Casanova AU - Mª Jesus Llorente Alonso AU - Irene Albarrán Lozano AU - Mª Paz Rodríguez Bolado AU - Asunciόn Flόrez Horcajada AU - Dolores Άlvaro Άlvarez Y1 - 2011/09/01 UR - http://erj.ersjournals.com/content/38/Suppl_55/2935.abstract N2 - Objectives: To determine the prevalence of anaemia in stable-phase COPD patients. To ascertain the differences in serum values of some biomarkers between COPD patients with and without anaemia.Population and methods: COPD stable outpatients were included. These patients were followed up in the respiratory clinic and none of them could meet any of de following exclusion criteria: moderate-severe exacerbations in the last two months; asthma, thyroid disease, cancer in the last 5 years, liver disease, chronic heart or renal failure, any origin blood loss background, B12 vitamin and folic acid deficit. A set of tests were performed, including lung function test, blood samples for hemogram and biochemistry and serum values of ultrasensitive CRP, IL6, IL8 and TNFalfa. Bootstrap methodology has been used in order to test differences between with and without anaemia group.Results: 130 patients were included, 116 (89,2%) were men, with an average age of 64,2 years (DS 8,4) and a FEV1% postbronchodilatador of 49,7% (DS 15,6). 8 patients showed anaemia (6,2%). A summary of the biomarkers results for each group is presented below.View this table:Conclusions: The anaemia prevalence in COPD is 6,2% in our study. We have found significant differences in serum values of IL6 between COPD patients with and without anaemia. The CRP serum values in patients with COPD and anaemia were higher than the values in patients without anaemia.This study has been partially financed by GlaxoSmithKline. SA. CRT114268. ER -